Causality Assessment for Suspected DILI During Clinical Phases of Drug Development

Causality assessment is a critical step in establishing the diagnosis of drug induced liver injury (DILI) during drug development. DILI may resemble almost any type of liver disease, and often presents a serious challenge to clinical investigators and drug makers. The diagnosis of DILI is largely ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Regev, Arie, Seeff, Leonard B., Merz, Michael, Ormarsdottir, Sif, Aithal, Guruprasad P., Gallivan, Jim, Watkins, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212150/
https://www.ncbi.nlm.nih.gov/pubmed/25352327
http://dx.doi.org/10.1007/s40264-014-0185-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212150/
https://www.ncbi.nlm.nih.gov/pubmed/25352327
http://dx.doi.org/10.1007/s40264-014-0185-4

Ejemplares similares